All 0 3 0 3 O
subjects 4 12 4 12 O
must 13 17 13 17 O
have 18 22 18 22 O
a 23 24 23 24 O
fresh 25 30 25 30 O
tumor 31 36 31 36 B-treatment
biopsy 37 43 37 43 I-treatment

Concomitant 0 11 44 55 O
malignancies 12 24 56 68 B-cancer

Major 0 5 69 74 B-clinical_variable
surgery 6 13 75 82 I-clinical_variable
less 14 18 83 87 O
than 19 23 88 92 O
4 24 25 93 94 B-upper_bound
weeks 26 31 95 100 I-upper_bound
before 32 38 101 107 O
the 39 42 108 111 O
start 43 48 112 117 O
of 49 51 118 120 O
the 52 55 121 124 O
study 56 61 125 130 O

Patients 0 8 131 139 O
with 9 13 140 144 O
known 14 19 145 150 O
allergies 20 29 151 160 O
to 30 32 161 163 O
egg 33 36 164 167 B-allergy_name
products 37 45 168 176 I-allergy_name
, 45 46 176 177 O
neomycin 47 55 178 186 B-allergy_name
, 55 56 186 187 O
or 57 59 188 190 O
tetanus 60 67 191 198 B-allergy_name
toxoid 68 74 199 205 I-allergy_name

Prior 0 5 206 211 O
adverse 6 13 212 219 O
reaction 14 22 220 228 O
to 23 25 229 231 O
tetanus 26 33 232 239 B-allergy_name
toxoid 34 40 240 246 I-allergy_name
- 40 41 246 247 I-allergy_name
containing 41 51 247 257 I-allergy_name
vaccines 52 60 258 266 I-allergy_name

